|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Tonix Pharmaceuticals Holding Corp.
| | | Phone: | (212) 980-9155 | Fax: | (212) 923-5700 | Year Established: | 2007 | Ticker: | TNXP | Exchange: | NASDAQ | Main Contact: | Benjamin Selzer, COO | | Other Contacts: | Jessica Morris, COO Bradley Saenger, CPA, CFO Bruce Daugherty, Ph.D., MBA, Senior Director. Clinical Development Seth Lederman, MD, Co-Founder, CEO & Chairman
| | Company Description | Tonix is developing next-generation medicines for common disorders of the central nervous system, including fibromyalgia and post-traumatic stress disorder. These disorders are characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and significant economic burden. | |
|
|
|
|
|